Literature DB >> 27494797

Use of panel testing for detection of antinuclear antibody in a resource-limited setting: an appraisal.

Ranjana Walker Minz1, Yashwant Kumar1, Biman Saikia1, Shashi Anand1, Subhash Varma2, Surjit Singh3.   

Abstract

OBJECTIVES: Despite an increase in the incidence of systemic connective tissue diseases (CTD), panel testing for detection of antinuclear antibodies (ANA) is not a routine practice in many health centers of the Indian subcontinent. Consequently, the data on its significance is scanty.
METHODS: To evaluate utility of panel testing, line immunoassay (LIA) and indirect immunofluorescence antinuclear antibody test (IIF-ANA) were performed in 321 cases of CTD.
RESULTS: Out of 321 serum samples screened by the above tests, 227 were positive and 18 were negative by both LIA and IIF-ANA. Additional 11/321 (3.4%) cases were picked up by LIA. SSA was most common specificity in these cases followed by SSA/SSB, SSB, Ro-52, Jo-1, dsDNA and nRNP/Sm.
CONCLUSION: Use of LIA along with IF-ANA and ELISA improves sensitivity of CTD screening.

Entities:  

Keywords:  ANA; CTD; Indirect immunofluorescence; LIA; dsDNA ELISA

Mesh:

Substances:

Year:  2016        PMID: 27494797     DOI: 10.1080/00325481.2016.1220808

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  1 in total

1.  Assessment of ideal serum dilution for screening of antinuclear antibodies by an indirect immunofluorescence method in diagnosis of autoimmune disorders.

Authors:  Vivek Vasdev; S K Patnaik; D S Bhakuni; K Shanmuganandan; A Bhayana; G Mullick; A Hegde; Ashwini Kumar; Abhishek Kumar; R Singh
Journal:  Med J Armed Forces India       Date:  2020-07-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.